Dinuclear tridentate Ru (II) complex with strong near-infrared light-triggered anticancer activity

L Wei, R Kushwaha, T Sadhukhan, H Wu… - Journal of Medicinal …, 2024 - ACS Publications
The design of the dinuclear Ru (II) complex (Ru2) with strong near-infrared (NIR) absorption
properties has been reported for efficient anticancer phototherapy. Under 700 nm LED light …

[HTML][HTML] The Role of the Tumor Microenvironment in Triple-Positive Breast Cancer Progression and Therapeutic Resistance

Q Pu, H Gao - Cancers, 2023 - mdpi.com
Simple Summary This is an important point of view that the development of breast
carcinogenesis is not only related to the intrinsic characteristics of the cancer cells, but that it …

[HTML][HTML] De-escalating axillary surgery in node-positive breast cancer treated with neoadjuvant systemic therapy

SR de Wild, JM Simons, MJTFD Vrancken Peeters… - Breast Care, 2021 - karger.com
Background: There is a trend towards de-escalating axillary staging and treatment in breast
cancer patients. On account of neoadjuvant systemic therapy, node-positive breast cancer …

Prognostic effect of nodal status before and after neoadjuvant chemotherapy in breast cancer: a Dutch population-based study

SR de Wild, LB Koppert, L de Munck… - Breast cancer research …, 2024 - Springer
Purpose In breast cancer, neoadjuvant chemotherapy (NAC) can downstage the nodal
status, and can even result in a pathological complete response, which is associated with …

Level I axillary dissection in patients with breast cancer and tumor-involved sentinel lymph node after NAC is not sufficient for adequate nodal staging

J Žatecký, O Coufal, M Holánek… - Turkish Journal of …, 2023 - pmc.ncbi.nlm.nih.gov
Objectives The purpose of the study was to investigate the oncological sufficiency of level I
axillary dissection for adequate histological nodal staging (ypN) in patients with breast …

Disease extent according to baseline [18F]fluorodeoxyglucose PET/CT and molecular subtype: prediction of axillary treatment response after neoadjuvant systemic …

FJG van Amstel, CM de Mooij, JM Simons… - British Journal of …, 2024 - academic.oup.com
Background Axillary disease extent according to baseline [18F] fluorodeoxyglucose PET/CT
combined with pathological axillary treatment response has been proposed to guide de …

Oncological outcomes of selective axillary dissection with 4% carbon marking

LR Budel, CC Spautz, MH Louveira… - Revista do Colégio …, 2024 - SciELO Brasil
Introduction: The use of axillary marking prior to Neoadjuvant Systemic Therapy (NST) is a
controversial matter regarding patients with positive Lymph Nodes (LN). Several methods …

[HTML][HTML] Trends of axillary surgery in breast cancer patients with axillary lymph node metastasis: a comprehensive single-center retrospective study

YJ Kim, HJ Kim, SY Chung, SK Lee… - Annals of Surgical …, 2023 - synapse.koreamed.org
Purpose Based on the results of previous trials, de-escalation of axillary surgery after
neoadjuvant chemotherapy (NAC) has increased in patients with axillary lymph node (ALN) …

Desfechos oncológicos da dissecção axilar seletiva utilizando carvão a 4% como marcador

LR Budel, CC Spautz, MH Louveira… - Revista do Colégio …, 2024 - SciELO Brasil
Introdução: O uso de marcadores na axila antes da terapia sistêmica neoadjuvante (TSN) é
um tema controverso em mulheres com linfonodos (LN) acometidos. Diversos marcadores …

[PDF][PDF] Hubungan ekspresi E-Cadherin dengan status metastasis kelenjar getah bening pada triple negative breast cancer di rumah sakit umum pusat Dr

K Deschairul, D Puspasari, M Dewi - Kariadi. JIKK, 2022 - scholar.archive.org
HUBUNGAN EKSPRESI E-CADHERIN DENGAN STATUS METASTASIS KELENJAR GETAH
BENING PADA TRIPLE NEGATIVE BREAST CANCER Di RUMAH SAKIT U Page 1 …